MacroCure's IPO

MacroCure raised a round of funding on July 31, 2014. Investors include Public.

Macrocure is a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous le…

Articles about MacroCure's IPO: